Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria

Mario Tumbarello, Teresa Spanu, Massimo Antonelli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

95 Citazioni (Scopus)

Abstract

The increasing frequency of ventilator-associated pneumonia (VAP) caused by colistin-only susceptible (COS) gram-negative bacteria (GNB) is of great concern. Adjunctive aerosolized (AS) colistin can reportedly increase alveolar levels of the drug without increasing systemic toxicity. Good clinical results have been obtained in patients with cystic fibrosis, but conflicting data have been reported in patients with VAP.
Lingua originaleEnglish
pagine (da-a)1768-1775
Numero di pagine8
RivistaChest
Volume144
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • VAP
  • colistin

Fingerprint

Entra nei temi di ricerca di 'Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria'. Insieme formano una fingerprint unica.

Cita questo